These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9140917)

  • 21. Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro.
    Rudolf MP; Fausch SC; Da Silva DM; Kast WM
    J Immunol; 2001 May; 166(10):5917-24. PubMed ID: 11342606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of HPV16 capsid protein-specific human T cell responses by virus-like particles.
    Rudolf MP; Nieland JD; DaSilva DM; Velders MP; Müller M; Greenstone HL; Schiller JT; Kast WM
    Biol Chem; 1999 Mar; 380(3):335-40. PubMed ID: 10223336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of CD4(+)- and CD8(+)-T-cell responses to human papillomavirus type 1 antigens expressed at various stages of the virus life cycle by using an enzyme-linked immunospot assay of gamma interferon release.
    Steele JC; Roberts S; Rookes SM; Gallimore PH
    J Virol; 2002 Jun; 76(12):6027-36. PubMed ID: 12021335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine production from murine CD4 and CD8 cells after mannan-MUC1 immunization.
    Lees CJ; Apostolopoulos V; McKenzie IF
    J Interferon Cytokine Res; 1999 Dec; 19(12):1373-9. PubMed ID: 10638706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
    Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
    Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of IL-5 ELISPOT assays to quantification of antigen-specific T helper responses.
    Bennouna J; Hildesheim A; Chikamatsu K; Gooding W; Storkus WJ; Whiteside TL
    J Immunol Methods; 2002 Mar; 261(1-2):145-56. PubMed ID: 11861073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.
    Pinto LA; Viscidi R; Harro CD; Kemp TJ; García-Piñeres AJ; Trivett M; Demuth F; Lowy DR; Schiller JT; Berzofsky JA; Hildesheim A
    Virology; 2006 Sep; 353(2):451-62. PubMed ID: 16863657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developments in L2-based human papillomavirus (HPV) vaccines.
    Schellenbacher C; Roden RBS; Kirnbauer R
    Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of human papilloma virus L1 virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation.
    de Witte L; Zoughlami Y; Aengeneyndt B; David G; van Kooyk Y; Gissmann L; Geijtenbeek TB
    Immunobiology; 2007; 212(9-10):679-91. PubMed ID: 18086370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of immune responses induced by human papillomavirus type 18 L1-E6 and L1-E7 chimeric gene DNA vaccines in mice].
    Li A; Yang J; Lai BC; Geng YP; Wang Y; Wang YL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):760-3. PubMed ID: 15555456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice.
    Liu XS; Abdul-Jabbar I; Qi YM; Frazer IH; Zhou J
    Virology; 1998 Dec; 252(1):39-45. PubMed ID: 9875315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel Human Papillomavirus 16 L1 Pentamer-Loaded Hybrid Particles Vaccine System: Influence of Size on Immune Responses.
    Jia C; Yang T; Liu Y; Zhu A; Yin F; Wang Y; Xu L; Wang Y; Yan M; Cai Q; Liang X; Ju R; Chen J; Wang L
    ACS Appl Mater Interfaces; 2018 Oct; 10(42):35745-35759. PubMed ID: 30360122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of vaccine delivery system on the induction of HPV16L1-specific humoral and cell-mediated immune responses in immunized rhesus macaques.
    Tobery TW; Smith JF; Kuklin N; Skulsky D; Ackerson C; Huang L; Chen L; Cook JC; McClements WL; Jansen KU
    Vaccine; 2003 Mar; 21(13-14):1539-47. PubMed ID: 12615451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-vaccination with adeno-associated virus vectors encoding human papillomavirus 16 L1 proteins and adenovirus encoding murine GM-CSF can elicit strong and prolonged neutralizing antibody.
    Liu DW; Chang JL; Tsao YP; Huang CW; Kuo SW; Chen SL
    Int J Cancer; 2005 Jan; 113(1):93-100. PubMed ID: 15386434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunogenicity study of HPV 6b virus-like particles].
    Liu Y; Liu X; Frazer IH
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):587-9. PubMed ID: 12133476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers.
    Evans TG; Bonnez W; Rose RC; Koenig S; Demeter L; Suzich JA; O'Brien D; Campbell M; White WI; Balsley J; Reichman RC
    J Infect Dis; 2001 May; 183(10):1485-93. PubMed ID: 11319684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.
    Ohlschläger P; Osen W; Dell K; Faath S; Garcea RL; Jochmus I; Müller M; Pawlita M; Schäfer K; Sehr P; Staib C; Sutter G; Gissmann L
    J Virol; 2003 Apr; 77(8):4635-45. PubMed ID: 12663770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of CD4(+) T-cell responses to human papillomavirus (HPV) type 11 L1 in healthy adults reveals a high degree of responsiveness and cross-reactivity with other HPV types.
    Williams OM; Hart KW; Wang EC; Gelder CM
    J Virol; 2002 Aug; 76(15):7418-29. PubMed ID: 12097554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of dendritic cells and induction of T cell responses by HPV 16 L1/E7 chimeric virus-like particles are enhanced by CpG ODN or sorbitol.
    Freyschmidt EJ; Alonso A; Hartmann G; Gissmann L
    Antivir Ther; 2004 Aug; 9(4):479-89. PubMed ID: 15456078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model.
    Monroy-García A; Gómez-Lim MA; Weiss-Steider B; Hernández-Montes J; Huerta-Yepez S; Rangel-Santiago JF; Santiago-Osorio E; Mora García Mde L
    Arch Virol; 2014 Feb; 159(2):291-305. PubMed ID: 23990055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.